Drug Trial Radar · NCT07819799
Safety, Tolerability and PK of ATTO 1091 in Healthy Adult Volunteers and Patients With Ulcerative Colitis
Last checked: Nov 20, 2026Latest source record: Sep 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
96
Planned (sponsor's estimate)
Start
Dec 14, 2026
Primary completion
Jul 15, 2028
Study completion Jul 15, 2028
Sponsor
- Lead sponsor
- Attovia Therapeutics IncIndustry
- Sponsor type
- Industry
- First posted
- Sep 15, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to assess the safety, tolerability, and pharmacokinetics (PK) of ATTO-1091 in healthy adults and patients with ulcerative colitis. The main questions it aims to answer are: What medical problems do participants have when taking ATTO-1091? How long does ATTO-1091 stay in the body after dosing? Researchers will compare ATTO-1091 to a placebo (a look-alike substance that contains no drug). Participants will be dosed with ATTO-1091 or a placebo, visit the clinic for checkups and tests, and keep a diary of their symptoms.
Conditions
- Ulcerative Colitis (UC)
Interventions
ATTO-1091Drug
ATTO-1091
PlaceboDrug
Placebo preparation to match ATTO-1091 dose
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of AEsTime frame: 0-169 Days for SAD; 0-204 Days for MAD in HV; 0-141 Days for MAD in UC
- Incidence of laboratory abnormalitiesTime frame: 0-169 Days for SAD; 0-204 Days for MAD in HV; 0-141 Days for MAD in UC
- Incidence of ECG abnormalitiesTime frame: 0-169 Days for SAD; 0-204 Days for MAD in HV; 0-141 Days for MAD in UC
- Incidence of vital sign abnormalitiesTime frame: 0-169 Days for SAD; 0-204 Days for MAD in HV; 0-141 Days for MAD in UC
Locations
No sites are listed on the registry yet.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.